Ingredient or product comparison
The Unvarnished Truth About GHK-Cu In Vitro vs In Vivo
Here's the honest answer: in vitro data on GHK-Cu is compelling. The gene expression changes, proliferation rates, and collagen synthesis increases are real and reproducible across dozens of published studies. But in vitro models can't capture systemic bioavai
This source-based comparison does not add ratings or recommend a winner.
- Here's the honest answer: in vitro data on GHK-Cu is compelling. The gene expression changes, proliferation rates, and collagen synthesis increases are real and reproducible across dozens of published studies. But in vitro models can't capture systemic bioavailability, enzymatic degradation in plasma, or the immune system's response to peptide introduction. A peptide that increases collagen synthesis 3-fold in a Petri dish may produce a 20% increase in vivo because it's cleared within minutes by serum peptidases or sequestered by albumin before reaching target tissue. In vitro research tells you what GHK-Cu can do at the cellular level. Not necessarily what it will do in a living organism. That gap is why topical formulations (which deliver higher local concentrations) show more consistent clinical effects than systemic administration. The mechanism is proven; the delivery challenge remains.